Home > Postgraduate > Pharmacology > Manchester > PGcert Translational Medicine: Pharmaceutical Cancer - Manchester - Greater Manchester

PGcert Translational Medicine: Pharmaceutical Cancer

Speak without obligation to University of Manchester

To contact you must accept the privacy policy

Comments about PGcert Translational Medicine: Pharmaceutical Cancer - At the institution - Manchester - Greater Manchester

  • Objectives
    The aim of the PGCert is to give individuals a thorough knowledge and understanding of the research methods used in academic translational medicine (option A) or within the drug discovery departments of the major pharmaceutical manufacturers (option B). The programme will therefore serve to aid individuals in obtaining laboratory based positions and to facilitate the careers of those who are already employed within academia or the pharmaceutical industry
  • Entry requirements
    Entry requirements: A minimum 2:1 honours degree (or equivalent) in the biomedical sciences. International candidates must have obtained the equivalent of a 2:1 in a related degree from a reputed University. Candidates on the undergraduate medical programme must have satisfactorily completed years 1-4 of the MBChB with no failure at any examination. For St Andrews students this includes their 3 year degree programme and the following 2 years spent in Manchester (years 3 and 4 of the Manchester programme). Students with evidence of previous advanced study, research or professional experience may be accepted by the University as qualification for entry
  • Academic Title
    PGcert Translational Medicine: Pharmaceutical Cancer
  • Course description
    Course description

    The programme is designed to give students a thorough knowledge and understanding of the key technologies used in the field of Translational Medicine either within an academic environment or the pharmaceutical industry. The postgraduate certificate in Research Methods for Translational Medicine has two distinct tracks:

    Option A: Interdisciplinary Molecular Medicine

    Option B: Pharmaceutical Cancer Translational Medicine

    The course consists of 8 one week taught course units; four core compulsory units and 4 units from either option A or B.

    Module details

    There are four core course units which are taken regardless of the pathway selected. These are:

    1. Research Design and Implementation

    2. Quantitative Technologies for Translational Medicine

    3. Data analysis

    4. Delivering a Translational Medicine Strategy in a Matrix Structure

    Depending on the option chosen the students then take an additional four course units:

    OPTION A

    5A. Genetics, Genetic Epidemiology and Genomics

    6A. Transcriptomics and Functional Genomics

    7A. Proteomics

    8A. Metabolomics

    OPTION B

    5B. Assembling a pre-clinical strategy for a new candidate drug

    6B. Assembling an early clinical strategy for a new candidate drug

    7B. Assembling a Trasnlational Medicine strategy for a new anti-cancer drug

    8B. Pharmaceutical Translational Medicine: putting it all together.

Other programs related to Pharmacology

This site uses cookies. If you continue navigating, the use of cookies is deemed to be accepted. See more  |